tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Armata Pharmaceuticals: Promising Clinical Trials and Strong Financial Position Justify Buy Rating
RatingsArmata Pharmaceuticals: Promising Clinical Trials and Strong Financial Position Justify Buy Rating
10d ago
ARMP
Armata Pharmaceuticals reports Q4 EPS (23c) vs (55c) last year
PremiumThe Fly
Armata Pharmaceuticals reports Q4 EPS (23c) vs (55c) last year
11d ago
ARMP
Armata Pharmaceuticals Secures $10M Loan for Clinical Trials
PremiumCompany Announcements
Armata Pharmaceuticals Secures $10M Loan for Clinical Trials
19d ago
8K
ARMP
Armata Pharmaceuticals Reports Positive Phase 2 Study Results
PremiumCompany Announcements
Armata Pharmaceuticals Reports Positive Phase 2 Study Results
3M ago
8K
ARMP
Armata Pharma’s inhaled AP-PA02 shows positive results in Phase 2 study
PremiumThe Fly
Armata Pharma’s inhaled AP-PA02 shows positive results in Phase 2 study
3M ago
ARMP
Armata Pharmaceuticals Announces CMO Departure Agreement
PremiumCompany AnnouncementsArmata Pharmaceuticals Announces CMO Departure Agreement
4M ago
8K
ARMP
Armata Pharmaceuticals Extends Credit Agreement and CMO Departs
Premium
Company Announcements
Armata Pharmaceuticals Extends Credit Agreement and CMO Departs
5M ago
8K
ARMP
Armata Pharmaceuticals reports Q3 EPS (15c) vs. (86c) last year
Premium
The Fly
Armata Pharmaceuticals reports Q3 EPS (15c) vs. (86c) last year
5M ago
ARMP
Armata Completes Enrollment for Innovative Bacteriophage Study
PremiumCompany Announcements
Armata Completes Enrollment for Innovative Bacteriophage Study
5M ago
8K
ARMP
Armata Pharmaceuticals completes enrollment of Phase 1b/2a diSArm study
PremiumThe Fly
Armata Pharmaceuticals completes enrollment of Phase 1b/2a diSArm study
5M ago
ARMP
ARMP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ARMP Earnings this Week: How Will it Perform?
5M ago
ARMP
Armata Pharmaceuticals VP Richard Rychlik Departs with Benefits
PremiumCompany Announcements
Armata Pharmaceuticals VP Richard Rychlik Departs with Benefits
6M ago
8K
ARMP
Armata Pharmaceuticals Updates Progress and Corporate Presentation
PremiumCompany AnnouncementsArmata Pharmaceuticals Updates Progress and Corporate Presentation
7M ago
8K
ARMP
Armata Pharmaceuticals Welcomes David House as New SVP of Finance
Premium
Company Announcements
Armata Pharmaceuticals Welcomes David House as New SVP of Finance
8M ago
8K
ARMP
Armata Pharmaceuticals reports Q2 EPS (25c) vs. (17c) last year
Premium
The Fly
Armata Pharmaceuticals reports Q2 EPS (25c) vs. (17c) last year
8M ago
ARMP
ARMP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ARMP Earnings this Week: How Will it Perform?
8M ago
ARMP
Armata Pharmaceuticals receives $5.25M of funding from DoD
PremiumThe Fly
Armata Pharmaceuticals receives $5.25M of funding from DoD
8M ago
ARMP
Armata Pharmaceuticals Updates Chief Medical Officer’s Compensation
PremiumCompany Announcements
Armata Pharmaceuticals Updates Chief Medical Officer’s Compensation
8M ago
8K
ARMP
Armata Pharmaceuticals completes enrollment of Phase 2 study of AP-PA02
PremiumThe Fly
Armata Pharmaceuticals completes enrollment of Phase 2 study of AP-PA02
9M ago
ARMP
Armata Pharmaceuticals Under Pressure: Navigating the Risks as Cost-Cutting Measures Threaten Revenue
PremiumCompany AnnouncementsArmata Pharmaceuticals Under Pressure: Navigating the Risks as Cost-Cutting Measures Threaten Revenue
1y ago
ARMP
Armata Pharmaceuticals reports Q4 EPS (55c) vs. (29c) last year
Premium
The Fly
Armata Pharmaceuticals reports Q4 EPS (55c) vs. (29c) last year
1y ago
ARMP
ARMP Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ARMP Upcoming Earnings Report: What to Expect?
1y ago
ARMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >